Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fundic Gland Polyps: Strategizing a Surveillance Framework for Children and Adolescents.

Journal of pediatric gastroenterology and nutrition·2023
Same author

Culprit or Innocent Bystander? A Case of Hematemesis.

JPGN reports·2023
Same author

What Is a Honeymoon in Type 1, Can It Go into Remission?

Endocrinology and metabolism clinics of North America·2023
Same author

Has Vitamin D Lost It's (Sun) Shine?

Journal of pediatric gastroenterology and nutrition·2023
Same author

Cloning of ground-state intestinal stem cells from endoscopic biopsy samples.

Nature protocols·2020
Same author

Impact of a Quality Improvement Initiative to Optimize the Discharge Process of Pediatric Gastroenterology Patients at an Academic Children's Hospital.

Pediatric quality & safety·2019

Related Experiment Video

Updated: Jul 8, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Chronic pediatric inflammatory diseases: effects on bone.

Anuradha Viswanathan1, Francisco A Sylvester

  • 1University of Connecticut School of Medicine, Farmington, CT, USA. Aviswanathan@ccmckids.org

Reviews in Endocrine & Metabolic Disorders
|January 1, 2008
PubMed
Summary

Chronic inflammatory diseases in children can negatively impact bone health, leading to reduced bone mass and increased fracture risk. This overview examines the effects on skeletal development and potential interventions.

Related Experiment Videos

Last Updated: Jul 8, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Area of Science:

  • Pediatric rheumatology
  • Pediatric endocrinology
  • Pediatric bone health

Background:

  • Chronic inflammatory diseases (CIDs) pose a significant threat to long-term skeletal health in children.
  • CIDs are linked to poor nutrition, altered nutrient use, delayed puberty, inactivity, and reduced muscle mass, all impacting bone metabolism.
  • The immune response in CIDs directly affects bone cell activity, further compromising skeletal integrity.

Purpose of the Study:

  • To provide a comprehensive overview of how chronic inflammatory conditions affect bone mass in children.
  • To explore the pathogenesis of decreased bone mass in pediatric inflammatory diseases.
  • To include relevant data from adult patients where pediatric data are limited.

Main Methods:

  • Review of existing literature, primarily focusing on studies utilizing dual-energy X-ray absorptiometry (DXA).
  • Analysis of factors contributing to altered bone metabolism in children with CIDs.
  • Inclusion of adult patient data to supplement pediatric findings when necessary.

Main Results:

  • Deficits in bone mass are commonly observed in children with CIDs, as documented by DXA studies.
  • Wide variations in low bone mass prevalence exist, influenced by study population characteristics.
  • Glucocorticoid therapy, often used for CIDs, can negatively impact bone formation and linear growth.

Conclusions:

  • Children with CIDs are at risk of not achieving predicted peak bone mass, increasing short-term and future fracture risk.
  • Understanding the multifactorial impact of CIDs on bone health is crucial for effective management.
  • Further research is needed to optimize bone health strategies for pediatric patients with chronic inflammatory conditions.